Evaluation of Serum S-100B Protein Levels in Patients with Simple Febrile Convulsions

Abstract

Objective This study aimed at evaluating serum S-100B protein levels after convulsions in children experiencing simple febrile convulsions.

Material and Methods The study included 30 healthy children as the control group and 30 patients with simple febrile convulsions as the study group. Blood samples were obtained within 2 hours after the patients sustained febrile convulsions. Serum S-100B protein levels of the patients in the study group and the control group were measured using enzyme-linked immunosorbent assay kits.

Results There was no statistically significant difference between the groups, when the mean serum S-100B protein levels were compared between patients with febrile convulsions and the control group (p > 0.05).

Conclusion Lack of an increase in serum S-100B protein levels of patients with simple febrile convulsion suggests that febrile convulsive seizures do not cause any organ damage.

Keywords

simple febrile - convulsion - S-100B

• References

• 1 Gupta A. Febrile Seizures. Continuum (Minneap Minn) 2016; 22 (1 Epilepsy) 51-59
• 2 Lennox-Buchthal MA. Febrile convulsions. In: Laidlaw J, Richens A, eds. A Textbook of Epilepsy. 2nd ed. New York, NY: Churchill Livingston; 1982: 68-88
• 3 Kliegman RM, Stanton BF, Schor NF, Geme JW, Behrman RE. Seizures in childhood. In: Mikati MA, ed. Nelson Textbook of Pediatrics. 19th ed. Philadelphia, PA: Saunders; 2011: 2017-2019
• 4 Daoud A. Febrile convulsion: review and up date. J Pediatr Neurol 2003; 1 (2) 9-14
• 5 Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1999; 1450 (3) 191-231
• 6 Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965; 19 (6) 739-744
• 7 Kretsinger RH, Tolbert D, Nakayama S, Pearson W. The EF-hand, homologs and analogs. In: Heizmann CW, ed. Novel Calcium Binding Proteins. Fundamentals and Clinical Applications. New York, NY: Springer-Verlag; 2001: 17-37
• 8 Presland RB, Bassuk JA, Kimball JR, Dale BA. Characterization of two distinct calcium-binding sites in the amino-terminus of human profilaggrin. J Invest Dermatol 1995; 104 (2) 218-223
• 9 Mikkonen K, Pekkala N, Pokka T, Romner B, Uhari M, Rantala H. S100B proteins in febrile seizures. Seizure 2012; 21 (2) 144-146
• 10 Gazzolo D, Bruschettini M, Lituania M, Serra G, Santini P, Michetti F. Levels of S100B protein are higher in mature human milk than in colostrum and milk-formulae milks. Clin Nutr 2004; 23 (1) 23-26
• 11 Kligman D, Marshak DR. Purification and characterization of a neurite extension factor from bovine brain. Proc Natl Acad Sci U S A 1985; 82 (20) 7136-7139
• 12 Routsi C, Stamataki E, Nanas S , et al. Increased levels of serum S100B protein in critically ill patients without brain injury. Shock 2006; 26 (1) 20-24
• 13 Winningham-Major F, Staecker JL, Barger SW, Coats S, Van Eldik LJ. Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues. J Cell Biol 1989; 109 (6 Pt 1): 3063-3071
• 14 Van Eldik LJ, Christie-Pope B, Bolin LM, Shooter EM, Whetsell Jr WO. Neurotrophic activity of S-100 beta in cultures of dorsal root ganglia from embryonic chick and fetal rat. Brain Res 1991; 542 (2) 280-285
• 15 Racacho LJ, McLachlan RS, Ebers GC, Maher J, Bulman DE. Evidence favoring genetic heterogeneity for febrile convulsions. Epilepsia 2000; 41 (2) 132-139
• 16 Rothermundt M, Peters M, Prehn JH, Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Tech 2003; 60 (6) 614-632
• 17 Ingebrigtsen T, Romner B, Marup-Jensen S , et al. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Inj 2000; 14 (12) 1047-1055
• 18 Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ. Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 2000; 31 (11) 2670-2677
• 19 Foerch C, Singer OC, Neumann-Haefelin T, du Mesnil de Rochemont R, Steinmetz H, Sitzer M. Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol 2005; 62 (7) 1130-1134
• 20 Sanchez-Peña P, Pereira AR, Sourour NA , et al. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med 2008; 36 (8) 2267-2273
• 21 Rothermundt M, Falkai P, Ponath G , et al. Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry 2004; 9 (10) 897-899
• 22 Duke T, Curtis N, Fuller DG. The management of bacterial meningitis in children. Expert Opin Pharmacother 2003; 4 (8) 1227-1240
• 23 Lins H, Wallesch CW, Wunderlich MT. Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections. Acta Neurol Scand 2005; 112 (5) 303-308
• 24 Murayama T, Takahashi A, Asano T, Kato K. Elevated levels of the alpha subunit of GTP-binding protein Go in cerebrospinal fluid of patients with neurological disorders. J Mol Neurosci 1989; 1 (1) 27-32
• 25 Gazzolo D, Vinesi P, Bartocci M , et al. Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry. J Neurol Sci 1999; 170 (1) 32-35
• 26 Lu C, Li J, Sun W , et al. Elevated plasma S100B concentration is associated with mesial temporal lobe epilepsy in Han Chinese: a case-control study. Neurosci Lett 2010; 484 (2) 139-142
• 27 Calik M, Abuhandan M, Sonmezler A , et al. Elevated serum S-100B levels in children with temporal lobe epilepsy. Seizure 2013; 22 (2) 99-102
• 28 Portela LV, Tort AB, Walz R , et al. Interictal serum S100B levels in chronic neurocysticercosis and idiopathic epilepsy. Acta Neurol Scand 2003; 108 (6) 424-427
• 29 Atıcı Y, Alehan F, Sezer T , et al. Serum S100B levels in children with simple febrile seizures. Seizure 2012; 21 (3) 175-177